TAUG - Tauriga Sciences, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20193/31/20183/31/20173/31/2016
Total Revenue57.134---
Cost of Revenue37.128---
Gross Profit20.006---
Operating Expenses
Research Development13.92410.06833.94233.942
Selling General and Administrative1,088.181,566.6111,432.6532,027.633
Non Recurring----
Others----
Total Operating Expenses1,140.1961,577.4751,473.6292,037.465
Operating Income or Loss-1,083.062-1,577.475-1,473.629-2,037.465
Income from Continuing Operations
Total Other Income/Expenses Net-12.1811,579.987-701.892-435.728
Earnings Before Interest and Taxes-1,083.062-1,577.475-1,473.629-2,037.465
Interest Expense-280.587-291.61-721.408-83.456
Income Before Tax-1,095.2432.512-2,175.521-2,473.193
Income Tax Expense----
Minority Interest--2.196-2.196-2.196
Net Income From Continuing Ops-1,095.2432.512-2,175.521-2,473.193
Non-recurring Events
Discontinued Operations-2.196-77.313-77.313-95.96
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-1,097.439-36.127-2,175.521-2,569.153
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-1,097.439-307.407-2,271.3-2,569.153